Therapure Biopharma Inc. Recognized for Innovation & Leadership at IAIR Awards in New York
Mississauga, Ontario, Canada (April 22, 2014) – Therapure Biopharma Inc. announced today that it has been recognized for the Best Company for Innovation & Leadership – Biologics – Canada at the IAIR (International Alternative Investment Review) Awards ceremony in New York City on April 15, 2014.
The award was the result of a survey of over 50,000 IAIR online journal readers followed by a selection process by the IAIR judging panel based on the organization’s contributions to the community and industry. Stating the reason for selecting Therapure, the IAIR Awards said that, “Therapure was recognized for being specialists in biologics, striving to exceed their own expectations as well as those of their clients, partners, investors and regulators. Through a strong team, knowledge, quality systems and capital assets, Therapure Biopharma maintains itself at an industry-leading level.”
In accepting the award, Mr. Brian Fielding, Chief Financial Officer of Therapure, said “Innovation and leadership are critical to the growth of the organization to foster productivity and quality. Our success is more than having superior technology – it’s having experienced people who are passionate, responsive and committed to developing and manufacturing biotherapeutics to improve patient lives.”
The gala awards dinner took place at the Yale Club of New York on April 15, 2014. The event was attended by approximately 200 business professionals from a variety of industries. For more information about the awards, please visit www.iairawards.com
Therapure Biopharma Inc. is a biopharmaceutical company focused on complex biological therapeutics and technologies. It is comprised of Therapure Biomanufacturing, the contract development and manufacturing division and Therapure Innovations, the proprietary therapeutics and platform technologies research and development division. Therapure Biopharma Inc.’s 130,000 sq. ft. facility includes research laboratories, cGMP biomanufacturing and aseptic fill/finish suites, as well as quality control laboratories built to meet FDA (USA), HPFB (Canada) and EMA (Europe) standards.
For more information, please visit: www.therapurebio.com
Director, Marketing and Special Projects